| __timestamp | Biogen Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 85181000 |
| Thursday, January 1, 2015 | 2012800000 | 135253000 |
| Friday, January 1, 2016 | 1973300000 | 162297000 |
| Sunday, January 1, 2017 | 2253600000 | 198442000 |
| Monday, January 1, 2018 | 2597200000 | 226616000 |
| Tuesday, January 1, 2019 | 2280600000 | 299726000 |
| Wednesday, January 1, 2020 | 3990900000 | 335375000 |
| Friday, January 1, 2021 | 2501200000 | 505748000 |
| Saturday, January 1, 2022 | 2231100000 | 590453000 |
| Sunday, January 1, 2023 | 2702600000 | 849658000 |
| Monday, January 1, 2024 | 2041800000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Biogen Inc. and Jazz Pharmaceuticals plc have demonstrated contrasting strategies in their R&D investments. Biogen, a leader in neuroscience, has consistently allocated substantial resources, with a peak in 2020 where R&D expenses surged by 60% compared to 2014. This reflects their aggressive pursuit of breakthroughs in neurological disorders. Meanwhile, Jazz Pharmaceuticals, known for its focus on sleep and hematology/oncology, has shown a steady increase in R&D spending, culminating in a nearly tenfold rise by 2023. This growth underscores their strategic expansion into new therapeutic areas. As these companies continue to innovate, their R&D investments will likely shape the future of healthcare, offering hope for groundbreaking treatments.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.